Non-US Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease

NCT00533273 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Dupuytren's Disease

Interventions

BIOLOGICAL: collagenase clostridium histolyticum

Sponsor

Endo Pharmaceuticals